Welcome to HPM

HPM is an independent contract research organisation offering services in the area of drug safety. Our dedicated teams of physicians, pharmacists and scientists provide a full range of services in these areas tailored to meet the specific needs of our clients.

Our drug safety team provides a broad range of services in drug safety including the full management of pre- and post-authorization adverse events, access to a validated drug safety database, expedited reporting in accordance with the national and international requirements, writing services of all safety-related documents, and support in setting up your standard operating procedures.

Based in Geneva, at the heart of Europe, HPM is recognized as a post-graduate training facility by the Federation of Swiss Physicians (FMH).

[Close Box]

United Biosource Expands Global Drug Safety Capabilites

Acquisition of HPM (Geneva) SA Increases Capacity and Expertise

BETHESDA, MD (May 18, 2009) - United BioSource Corporation (UBC) today announced the acquisition of HPM (Geneva) SA, a Geneva, Switzerland-based provider of drug safety and pharmacovigilance services, further extending UBC’s reach into the European market. The acquisition of HPM (Healthcare Project Management) represents a strategic expansion of UBC’s market-leading safety and risk management services, which include comprehensive safety reporting, case processing, and integrated pharmacovigilance services.

“We are very excited to add the vast experience and services of the HPM team to the UBC family and equally pleased to enhance our growing global presence with our first office in Switzerland, from which we intend to offer the portfolio of UBC’s evidence-generating offerings,” said Ethan Leder, CEO of United BioSource Corporation. Leder added, “HPM has deep experience and offers sophisticated solutions in the operational and regulatory requirements related to drug safety, particularly with regard to the specific needs of European agencies.” Effective immediately, the Geneva office will be led by Executive Director Veronique Basch, PharmD and will operate as part of UBC’s global safety and risk management group. Following a successful career in drug safety with a major pharmaceutical company, Dr. Basch was responsible for establishing HPM’s drug safety operations.

“We are very pleased to be part of UBC,” said Pierre-Andre Lauener, MD, Managing Director and co-founder of HPM. “After building HPM for the past 12 years, we wanted to find a company with the same commitment to excellence in drug safety that has made HPM successful. With their expertise in REMS, late stage studies, and proven operational expertise, UBC is an ideal fit in that regard. We look forward to supporting our long-established clients with outstanding service and an even broader set of capabilities.”

UBC’s global drug safety and risk management services include the development and implementation of risk evaluation and mitigation systems (REMS) programs, performance-linked access systems (PLAS), periodic safety update reporting (PSUR), risk management plans, case processing, and integrated pharmacovigilance services. These services are provided with dedicated and integrated resources around the globe.

About HPM
HPM (Geneva) SA is a pharmaceutical services organization founded in 1997 with core capabilities in drug safety, pharmacovigilance consultancy and risk management services. For more information visit www.hpmgeneva.com.

About UBC
UBC accelerates the generation, analysis and communication of real world evidence by integrating scientific and operational expertise with innovative technology solutions to support global development and commercialization of medical products for life science companies.

The company is headquartered in Bethesda, Maryland, with offices located in the United States, United Kingdom, Europe, Latin America, and Japan. For more information about UBC, visit www.unitedbiosource.com.

United Biosource Corporation 7501 Wisconsin Avenue, Ste 705, Bethesda, Md 20814 Tel: 240 644-0420, Fax: 240 644-0421